PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer. Smit J, Borm FJ, Niemeijer AN, Huisman MC, et al. J Nucl Med 2021 Aug 12. pii: jnumed.121.262473. doi: 10.2967/jnumed.121.262473.

Read + Share

Amedeo Smart

Independent Medical Education

Smit J, Borm FJ, Niemeijer AN, Huisman MC, et al. PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer. J Nucl Med 2021 Aug 12. pii: jnumed.121.262473. doi: 10.2967/jnumed.121.262473.
PMID: 34385342